title: One year follow-up of steroid-free immunosuppression plus everolimus in isolated pancreas transplantation.
authors.forename: Fabrizio
authors.initials: F
authors.lastname: di Francesco
authors.forename: Nicola
authors.initials: N
authors.lastname: Cautero
authors.forename: Paolo
authors.initials: P
authors.lastname: Vincenzi
authors.forename: Daniele
authors.initials: D
authors.lastname: Nicolini
authors.forename: Stefano
authors.initials: S
authors.lastname: De Luca
authors.forename: Andrea
authors.initials: A
authors.lastname: Vecchi
authors.forename: Paolo
authors.initials: P
authors.lastname: Garelli
authors.forename: Giacomo
authors.initials: G
authors.lastname: Martorelli
authors.forename: Marco
authors.initials: M
authors.lastname: Gentili
authors.forename: Andrea
authors.initials: A
authors.lastname: Risaliti
authors.forename: Massimo
authors.initials: M
authors.lastname: Boemi
mesh_terms: D000328:Adult; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D000068338:Everolimus; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives; D016035:Pancreas Transplantation; D020123:Sirolimus / Q000008:administration & dosage / Q000031:analogs & derivatives*; D016559:Tacrolimus / Q000008:administration & dosage; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D000068338:Everolimus; D009173:Mycophenolic Acid; D020123:Sirolimus; D016559:Tacrolimus